1. Boehringer Ingelheim International Gmbh (28 from 1,536 patents)

2. Boehringer Ingelheim Pharma Kg (12 from 149 patents)

3. Boehringer Ingelheim Pharma Gmbh & Co Kg (10 from 194 patents)

4. Dr. Karl Thomae Gmbh (9 from 133 patents)

5. Karl Thomae Gmbh (3 from 36 patents)

6. Evotec International Gmbh (1 from 13 patents)

7. Neurocrine Biosciences, Inc. (120 patents)

8. Thomas Muller (0 patent)

9. Armin Heckel (0 patent)

10. Josef Nickl (0 patent)

11. Rainer Soyka (0 patent)

12. Christopher Meade (0 patent)

13. Johannes Weisenberger (0 patent)

14. Wolfgang Eisert (0 patent)

15. Gojko Muacevic (0 patent)

1. 11179371 - Triazole benzamide derivatives as GPR142 agonists

2. 10221202 - Annelated phenoxyacetamides

3. 10154990 - Medicaments for the treatment or prevention of fibrotic diseases

4. 10155749 - Substituted benzimidazolium compounds useful in the treatment of respiratory diseases

5. 9981954 - 2-(pyrazin-2-ylcarbonylaminomethyl) benzimidazolium compounds as epithelial sodium channel inhibitors

6. 9938256 - Annelated benzamides

7. 9932324 - Substituted benzimidazolium compounds useful in the treatment of respiratory diseases

8. 9920035 - Heterocyclic compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof

9. 9708274 - Sulfoximine substituted quinazolines for pharmaceutical compositions

10. 9469631 - N-cyclopropyl-N-piperidinyl-amides, pharmaceutical compositions containing them, and uses thereof

11. 9139577 - Sulfoximine substituted quinazolines for pharmaceutical compositions

12. 9126982 - Heterocyclic compounds, medicaments containing them, use and processes for the preparation thereof

13. 9096548 - Pyrazine amide compounds

14. 9078909 - Tertiary amines, medicaments containing said amines, use thereof and processes for the preparation thereof

15. 9073954 - 5-substituted benzimidazolium compounds